We build…
Gyes pushes the boundaries of multifunctional antibody science to discover breakthrough medicines.
… Multifunctional antibodies to combat disease
Precision antibody therapeutics
Gyes has developed the Multispecific Antibody Platform (the MAP): a set of phage-display libraries built to meet the highest standards of diversity, quality and developability.
Using the MAP, we discover and develop precision antibody therapeutics. Through their precise and multifunctional action, these antibodies can specifically affect disease-causing cells or strengthen the ability of immune cells to combat disease.
Our innovative antibodies are built to only become functional upon binding to combinations of targets co-expressed on select cell populations. In addition, we leverage grouping of receptors to potently activate cell signaling pathways.
… emergent companies backed by global venture capital
Gyes has created an engine of technology and expertise to build a network of global VC-supported companies to bring our multifunctional antibody therapeutics to the clinic.
Multifunctional antibodies that manipulate immune cells to combat cancer and autoimmune diseases.
Multifunctional antibodies for deep-depletion of tissue-resident, disease-causing cells.